Miravirsen
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Miravirsen, covering 2012-01-31 to 2017-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin